Maskapai Reasuransi Indonesia Stock Current Valuation

MREI Stock  IDR 945.00  20.00  2.07%   
Valuation analysis of Maskapai Reasuransi helps investors to measure Maskapai Reasuransi's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
945.00
Please note that Maskapai Reasuransi's price fluctuation is very steady at this time. Calculation of the real value of Maskapai Reasuransi is based on 3 months time horizon. Increasing Maskapai Reasuransi's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Maskapai Reasuransi's intrinsic value may or may not be the same as its current market price of 945.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  945.0 Real  900.94 Hype  945.0 Naive  953.54
The intrinsic value of Maskapai Reasuransi's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Maskapai Reasuransi's stock price.
899.89
Downside
900.94
Real Value
1,040
Upside
Estimating the potential upside or downside of Maskapai Reasuransi Indonesia helps investors to forecast how Maskapai stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Maskapai Reasuransi more accurately as focusing exclusively on Maskapai Reasuransi's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
948.96970.00991.04
Details
Hype
Prediction
LowEstimatedHigh
943.95945.00946.05
Details
Naive
Forecast
LowNext ValueHigh
952.49953.54954.59
Details

Maskapai Reasuransi Indonesia Company Current Valuation Analysis

Maskapai Reasuransi's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Maskapai Reasuransi Current Valuation

    
  1.61 T  
Most of Maskapai Reasuransi's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Maskapai Reasuransi Indonesia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Maskapai Reasuransi Indonesia has a Current Valuation of 1.61 T. This is much higher than that of the Insurance sector and significantly higher than that of the Financials industry. The current valuation for all Indonesia stocks is notably lower than that of the firm.

Maskapai Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Maskapai Reasuransi's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Maskapai Reasuransi could also be used in its relative valuation, which is a method of valuing Maskapai Reasuransi by comparing valuation metrics of similar companies.
Maskapai Reasuransi is currently under evaluation in current valuation category among its peers.

Maskapai Fundamentals

About Maskapai Reasuransi Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Maskapai Reasuransi Indonesia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maskapai Reasuransi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maskapai Reasuransi Indonesia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Maskapai Stock

Maskapai Reasuransi financial ratios help investors to determine whether Maskapai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maskapai with respect to the benefits of owning Maskapai Reasuransi security.